Incidence and mortality of lung cancer in countries with different human development index
10.19428/j.cnki.sjpm.2023.22838
- VernacularTitle:不同人类发展指数国家肺癌发病率和死亡率分析
- Author:
Xiaoqiong ZHU
1
;
Dongming JIANG
2
;
Jiaying SHEN
2
;
Zheyun NIU
2
;
Ming HU
3
;
Huixian ZENG
4
;
Zhiyu YANG
4
;
Zihan ZHANG
2
;
Cunxi ZHAO
1
;
Guangwen CAO
3
Author Information
1. School of Public Health， Anhui Medical University， Hefei， Anhui 230032， China
2. Medical College of Tongji University， Shanghai 430030， China
3. Faculty of Naval Medicine， Naval Medical University， Shanghai Key Laboratory of Medical Bioprotection， Key Laboratory of Biological Defense， Shanghai 200433， China
4. School of Medicine， Jinan University， Guangzhou， Guangdong 510632， China
- Publication Type:Journal Article
- Keywords:
lung cancer;
human development index;
incidence;
mortality
- From:
Shanghai Journal of Preventive Medicine
2023;35(4):305-313
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo compare the annual and age trends of the age-standard incidence rate （ASIR） and the age-standard mortality rate （ASMR） of lung cancer in countries with different human development index （HDI） from 1990 to 2019. MethodsThe data were collected from the global burden of disease study and GLOBOCAN 2020. The average annual percentage change （AAPC） and age trends of ASIR and ASMR in lung cancer were analyzed by the Joinpoint regression model， and the comparison between the four groups was analyzed by Kruskale-Wallis analysis. ResultsIn 2020， the incidence and mortality of lung cancer gradually increased with age and HDI grade. From 1990 to 2019， the global ASIR and ASMR of lung cancer decreased， and the ASIR of lung cancer among male decreased， while the ASIR of lung cancer among female increased. The results showed that ASIR of lung cancer in female residents in countries with very high HDI increased significantly from 1996 to 2011， resulting in an overall upward trend in female ASIR， while the other groups showed a downward trend. It was found that ASIR and ASMR of lung cancer in China and India were on the rise， while ASIR and ASMR of lung cancer in Russia and the United States were on the decline. ConclusionAlthough very high/high HDI countries face a higher burden of lung cancer occurrence and death， the accumulation of lung cancer burden is completed in the transitioning period. Therefore， lung cancer prevention measures in countries in transition are critical for global lung cancer control.
